07.27.2021
Prevent & Delay
$3,432,469.00
46 months
Preclinical activities to advance D-peptides as an antigen-specific immunotherapy for type 1 diabetes
Funds support the preclinical development of an antigen-specific immunotherapy for type 1 diabetes (T1D).